HANNAH MADER: Open Payments
NPI 1922745280 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 19 payments from 10 companies in 2025. Trend: 2023 $107 · 2024 $1,686 · 2025 $438
Food & beverage: $438
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $102 |
| Janssen Biotech, Inc. | 4 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $76 |
| Celltrion USA Inc. | 2 | $46 |
| ORPHALAN INC | 1 | $33 |
| Madrigal Pharmaceuticals | 1 | $29 |
| Ardelyx, Inc. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
Products named: TREMFYA, ENTYVIO, SKYRIZI, RINVOQ, VEGZELMA, CUVRIOR, REZDIFFRA, IBSRELA.
Industry payments across UT — which companies pay providers there.
